NEOBLOC

देश: इसराइल

भाषा: अंग्रेज़ी

स्रोत: Ministry of Health

सक्रिय संघटक:

METOPROLOL TARTRATE

थमां उपलब्ध:

UNIPHARM LTD, ISRAEL

ए.टी.सी कोड:

C07AB02

फार्मास्यूटिकल फॉर्म:

TABLETS

रचना:

METOPROLOL TARTRATE 100 MG

प्रशासन का मार्ग:

PER OS

प्रिस्क्रिप्शन प्रकार:

Required

द्वारा बनाया गया:

UNIPHARM LTD, ISRAEL

चिकित्सीय क्षेत्र:

METOPROLOL

चिकित्सीय संकेत:

Cardio-selective beta receptor blocker for the treatment of hypertension and angina pectoris, antiarrhithmic, prophlaxis of myocardial reinfarction and migraine.

प्राधिकरण की तारीख:

2021-01-31

सूचना पत्रक

PATIENT PACKAGE INSERT IN ACCORDANCE
WITH THE PHARMACISTS’ REGULATIONS
)PREPARATIONS( – 1986
The medicine is dispensed with
a doctor’s prescription only
NEOBLOC
FILM-COATED TABLETS
COMPOSITION:
Each film-coated NEOBLOC tablet contains:
Metoprolol Tartrate 100 mg
For the list of inactive and allergenic ingredients
in the preparation, please see section 6 “Further
information”. Also see in section 2 “Important
information about some of the ingredients of the
medicine”.
READ THE LEAFLET CAREFULLY IN ITS ENTIRETY
BEFORE USING THE MEDICINE. This leaflet contains
concise information about the medicine. If you
have further questions, refer to the doctor or
pharmacist.
This medicine has been prescribed for the
treatment of your ailment. Do not pass it on to
others. It may harm them, even if it seems to you
that their medical condition is similar.
The medicine is not intended for children.
1. WHAT IS THE MEDICINE INTENDED FOR?
THERAPEUTIC ACTIVITY: Selective beta receptor
blocker for the treatment of hypertension, angina
pectoris and irregular heart rhythm, prevention
of migraine and prevention of myocardial
reinfarction.
THERAPEUTIC GROUP: selective beta receptor
blocker.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
• You are sensitive )allergic( to metoprolol, to
other beta blockers, or to any of the additional
ingredients contained in the medicine (see
section 6 “Further information”).
• You have heart conduction problems or heart
rhythm disturbances.
• You have severe or uncontrolled heart failure.
• You have cardiogenic shock.
• You have blocked blood vessels, including
blood circulation problems (a phenomenon
that can cause tingling or pallor/bluishness
in the hands or feet).
• You have a slow heart rate or have suffered a
heart attack and as a result now have a very
slow heart rate.
• You suffer from a sensation of pressure and
pain at rest (Prinzmetal’s angina).
• You have an untreated pheochromocytoma
(high blood pressure due to a tumor near the
kidney).
• You hav

उत्पाद विशेषताएं

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
NEOBLOC
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100mg metoprolol tartrate .
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablet The tablet can be divided into equal halves.
4
CLINICAL PARTICULARS
4.1
Therapeutic indications
Cardio-selective beta receptor blocker for the treatment of
hypertension and
angina pectoris,
antiarrhithmic, prophlaxis of myocardial reinfarction and migraine.
4.2
Posology and method of administration
Posology
_Hypertension: The usual starting dosage is generally 100 mg
metoprolol tartrate per _
_day. The dosage may be increased to 200 mg per day, as a single dose
or in divided _
_doses. _
_Angina Pectoris: 50-100 mg metoprolol tartrate, two or three times a
day. _
_ _
_Heart rhythm disturbances: 50 mg metoprolol tartrate, two or three
times a day. The _
_dosage may be increased up to 300mg per day, in divided doses. _
_ _
_Heart attack: 50 mg metoprolol tartrate every 6 hours. The
recommended _
_maintenance dose is 200 mg per day, in divided doses. The medicine
must be taken _
_for at least 3 months. _
_ _
_Prevention of Migraine: 100-200mg metoprolol tartrate daily, given in
divided doses _
_(morning and evening)._
_Paediatric population: Metoprolol tartrate is not intended for use in
children. _
_Renal and hepatic impairment:_ _Dose adjustment_
_may be necessary_
_._
Method of administration
Neobloc tablet should be swallowed with a little water, the tablet can
be halved for
immediate use.
There is no information about crushing or chewing the tablet.
4.3
Contraindications
•
Hypersensitivity to the active substance, other β-blockers or to any
of
the excipients listed in section 6.1
•
Asthma or history of bronchospasm
•
Atrioventricular block of second or third degree
•
Uncontrolled heart failure
•
Clinically relevant sinus bradycardia (< 45-50 bpm)
•
Pri
z
etal’s angina
•
Sick-sinus syndrome (unless a pacemaker is in situ)
•
Severe peripheral arterial dis